Cargando…
SGK1 mutation status can further stratify patients with germinal center B‐cell‐like diffuse large B‐cell lymphoma into different prognostic subgroups
There are over a 100 driver gene mutations in patients with diffuse large B‐cell lymphoma (DLBCL), but their clinical significance remains unclear. Here, we first analyzed the DLBCL dataset from the UK‐based Haematological Malignancy Research Network. Patients were divided into high‐ and low‐risk gr...
Autores principales: | Guo, Baoping, Huang, Yujie, Duan, Ying, Liao, Chengcheng, Cen, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894717/ https://www.ncbi.nlm.nih.gov/pubmed/35106936 http://dx.doi.org/10.1002/cam4.4550 |
Ejemplares similares
-
A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma
por: Cen, Hong, et al.
Publicado: (2015) -
Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors
por: Lu, Li, et al.
Publicado: (2019) -
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Subtype of the Thyroid
por: Waqar, Syed Hamza Bin, et al.
Publicado: (2021) -
Massive Transcriptional Perturbation in Subgroups of Diffuse Large B-Cell Lymphomas
por: Rosolowski, Maciej, et al.
Publicado: (2013) -
Ki67 Proliferation Index in Germinal and Non-Germinal Subtypes of Diffuse Large B-Cell Lymphoma
por: Hashmi, Atif A, et al.
Publicado: (2021)